Compare RGNT & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGNT | ALAR |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | Israel | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3M | 13.1M |
| IPO Year | 2022 | 2018 |
| Metric | RGNT | ALAR |
|---|---|---|
| Price | $1.74 | $1.60 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 42.0K | ★ 135.1K |
| Earning Date | 09-11-2026 | 11-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $24.89 |
| Revenue Next Year | N/A | $26.13 |
| P/E Ratio | ★ N/A | $44.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.23 | $1.16 |
| 52 Week High | $15.50 | $16.56 |
| Indicator | RGNT | ALAR |
|---|---|---|
| Relative Strength Index (RSI) | 38.13 | 40.27 |
| Support Level | $1.23 | $1.16 |
| Resistance Level | $2.48 | $2.10 |
| Average True Range (ATR) | 0.11 | 0.15 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 7.27 | 11.32 |
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment: web data collection. Geographically, it derives maximum revenue from China, followed by the United States, Europe, Hong Kong, Asia-Pacific, U.K. Virgin Islands, Israel, United Arab Emirates, Middle East & Africa and other.